SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-048568
Filing Date
2019-09-04
Accepted
2019-09-04 07:05:59
Documents
3
Period of Report
2019-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-18242_18k.htm 8-K 31621
2 EX-99.1 a19-18242_1ex99d1.htm EX-99.1 11668
3 GRAPHIC g182421mmi001.jpg GRAPHIC 3113
  Complete submission text file 0001104659-19-048568.txt   49013
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 191073294
SIC: 2836 Biological Products, (No Diagnostic Substances)